» Articles » PMID: 16280076

Tat Gets the "green" Light on Transcription Initiation

Overview
Journal Retrovirology
Publisher Biomed Central
Specialty Microbiology
Date 2005 Nov 11
PMID 16280076
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

Human immunodeficiency virus type 1 (HIV-1) Tat transactivation is an essential step in the viral life cycle. Over the past several years, it has become widely accepted that Tat exerts its transcriptional effect by binding the transactivation-responsive region (TAR) and enhancing transcriptional elongation. Consistent with this hypothesis, it has been shown that Tat promotes the binding of P-TEFb, a transcription elongation factor composed of cyclin T1 and cdk9, and the interaction of Tat with P-TEFb and TAR leads to hyperphosphorylation of the C-terminal domain (CTD) of RNA Pol II and increased processivity of RNA Pol II. A recent report, however, has generated renewed interest that Tat may also play a critical role in transcription complex (TC) assembly at the preinitiation step. Using in vivo chromatin immunoprecipitation assays, the authors reported that the HIV TC contains TBP but not TBP-associated factors. The stimulatory effect involved the direct interaction of Tat and P-TEFb and was evident at the earliest step of TC assembly, the TBP-TATA box interaction. In this article, we will review this data in context of earlier data which also support Tat's involvement in transcriptional complex assembly. Specifically, we will discuss experiments which demonstrated that Tat interacted with TBP and increased transcription initiation complex stability in cell free assays. We will also discuss studies which demonstrated that over expression of TBP alone was sufficient to obtain Tat activated transcription in vitro and in vivo. Finally, studies using self-cleaving ribozymes which suggested that Tat transactivation was not compatible with pausing of the RNA Pol II at the TAR site will be discussed.

Citing Articles

Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets.

Raines S, Falcinelli S, Peterson J, Van Gulck E, Allard B, Kirchherr J Antimicrob Agents Chemother. 2024; 68(7):e0020124.

PMID: 38829049 PMC: 11232404. DOI: 10.1128/aac.00201-24.


HIV-1 transcriptional modulation: novel host factors and prospective therapeutic strategies.

Gibaut Q, Mori L, Valente S Curr Opin HIV AIDS. 2023; 18(5):264-272.

PMID: 37535041 PMC: 10403276. DOI: 10.1097/COH.0000000000000808.


The chaperone protein p32 stabilizes HIV-1 Tat and strengthens the p-TEFb/RNAPII/TAR complex promoting HIV transcription elongation.

Li C, Mori L, Lyu S, Bronson R, Getzler A, Pipkin M Proc Natl Acad Sci U S A. 2022; 120(1):e2217476120.

PMID: 36584296 PMC: 9910500. DOI: 10.1073/pnas.2217476120.


Cure and Long-Term Remission Strategies.

Mori L, Valente S Methods Mol Biol. 2022; 2407:391-428.

PMID: 34985678 DOI: 10.1007/978-1-0716-1871-4_26.


Mutations altering acetylated residues in the CTD of HIV-1 integrase cause defects in proviral transcription at early times after integration of viral DNA.

Winans S, Goff S PLoS Pathog. 2020; 16(12):e1009147.

PMID: 33351861 PMC: 7787678. DOI: 10.1371/journal.ppat.1009147.


References
1.
Pumfery A, Deng L, Maddukuri A, de la Fuente C, Li H, Wade J . Chromatin remodeling and modification during HIV-1 Tat-activated transcription. Curr HIV Res. 2004; 1(3):343-62. DOI: 10.2174/1570162033485186. View

2.
Hori R, Xu S, Hu X, Pyo S . TFIIB-facilitated recruitment of preinitiation complexes by a TAF-independent mechanism. Nucleic Acids Res. 2004; 32(13):3856-63. PMC: 506799. DOI: 10.1093/nar/gkh711. View

3.
Kiefer H, Hanley T, Marcello J, Karthik A, Viglianti G . Retinoic acid inhibition of chromatin remodeling at the human immunodeficiency virus type 1 promoter. Uncoupling of histone acetylation and chromatin remodeling. J Biol Chem. 2004; 279(42):43604-13. DOI: 10.1074/jbc.M408069200. View

4.
Cato A, Henderson D, Ponta H . The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region. EMBO J. 1987; 6(2):363-8. PMC: 553404. DOI: 10.1002/j.1460-2075.1987.tb04763.x. View

5.
Kao S, Calman A, Luciw P, Peterlin B . Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature. 1987; 330(6147):489-93. DOI: 10.1038/330489a0. View